2022 May Last Updated
Annals of Hepato-Biliary-Pancreatic Surgery (Ann Hepatobiliary Pancreat Surg, AHBPS), the official publication of the Korean Association of Hepato-Biliary-Pancreatic Surgery, is an international, peer-reviewed open access journal. This journal publishes original basic and clinical research on diseases of the liver, biliary system and pancreas. The aim of this journal is to make contribution to saving lives of patients with hepatobiliary pancreatic diseases through active communication and exchange of study information on hepatobiliary pancreatic diseases and provision of education and training on the diseases. Korean Journal of Hepato-Biliary-Pancreatic Surgery was launched in 1997 with the Korean and English languages. From May 2012, this journal has published only in English. This journal was renamed as Annals of Hepato-Biliary-Pancreatic Surgery in October 2016.
Manuscripts should be submitted electronically (http://ahbps.org) The journal is published in a printed and an electronic version only in English. The Journal publishes invited articles, review articles, How-I-Do-It technical reports, case reports, letter to editor and editorials. Submissions are accepted only on the understanding that they have not been submitted elsewhere and have not been published elsewhere.
This journal is published four times a year and the publication dates are the last day of the month of February, May, August, and November of each year. All submitted articles are peer-reviewed by three members of the Editorial Committee which determines acceptance of the articles. Publication guidelines not stated here follow the general principles. Its editorial policies are the responsibility of the Editor-in-Chief and the Editorial Board under the general authority of the Editorial Committee.
The Editorial Office Contact Information
Annals of Hepatobiliary Pancreatic Surgery
101-2203, Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
Tel: +82-70-4252-8298, Fax: +82-2-2051-8298
All submitted papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. The journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with this Journal. Proofs will be sent to the corresponding author for final approval. Accepted manuscripts become the permanent property of this journal and may not be reproduced by any means, in whole or in part without the written permission of both the author and the publisher.
- 1. General ethical guidelines
- The journal adheres to the ethical guidelines for research and publication described in ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’ (http://www.icmje.org; International Committee of Medical Journal Editors [ICMJE]), ‘Good Publication Practice Guidelines for Medical Journals’ (http://kamje.or.kr/publishing_ethics.html; Korean Association of Medical Journal Editors [KAMJE]), and ‘Guidelines on Good Publication’ (http://publicationethics.org/resources/guidelines; Committee on Publication Ethics [COPE]).
For issues not addressed in these instructions, the author is referred to the ICMJE “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals” (http://www.icmje.org). Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: http://publicationethics.org/resources/flowcharts. If correction is needed, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control available from:
- 2. Authorship
- Authorship should be based on one of following contributions: (a) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work, (b) drafting the work or revising it critically for important intellectual content, (c) final approval of the version to be published, (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Any persons who do not meet the 4 criteria above should be placed as contributors in ACKNOWLEDGMENTS section. Authors submitting to this journal will be required to indicate the contribution, each has made to the manuscript. Any changes to the author list after submission, such as a change in the order of the authors, or the deletion or addition of authors, needs to be approved by a letter requesting the change signed by all the authors participating.
- 3. Conflicts of interest
- The corresponding author of an article is asked to inform the Editor of the authors' potential conflicts of interest possibly influencing their interpretation of data. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. A potential conflict of interest should be disclosed in the manuscript even when the authors are confident that their judgments have not been influenced in preparing the manuscript. The disclosure form should be the same as the ICMJE Uniform Disclosure Form for Potential Conflicts of Interest
- 4. Copyright
- The copyright for the manuscript published in this journal is owned by the Korean Association of Hepato-Biliary-Pancreatic Surgery. However, the legal responsibility for the content lies entirely with the authors. It is a violation of the regulations to present data on a paper that has been decided to be published but has not been published, and the use of published papers for commercial advertising purposes is prohibited. However, in case of an emergency in public health, prior consultation can be made with society.
- 5. Informed consent
- Human study must conform to ethical standards, and be approved by the appropriate Institutional Review Board (IRB). A statement concerning IRB approval and consent procedures must appear at the Methods section. Any systematic data gathering effort in patients or volunteers must be approved by an IRB or adhere to appropriate local/national regulations. Authors may be questioned about the details of consent forms or the consent process. On occasion, the Editor-in-Chief may request a copy of the approved IRB application from the author.
- 6. Statement of human and animal right
- Clinical research studies must state that the work was done in accordance with the Ethical Principles for Medical Research Involving Human Subjects outlined in the Helsinki Declaration in 1975 (revised in 2013). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. Human subjects must not be identifiable. Patients’ name, initial, hospital number, date of birth, or other protected healthcare information must not be disclosed. Animal research studies must state that the work was performed according to National or Institutional Guide for the Care and Use of Laboratory Animals, and the ethical treatment of all experimental animals must be observed.
- 7. Originality and duplicate publication
- All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Manuscripts are only accepted for publication in journals if they have not been published elsewhere. No part of the accepted manuscript should be duplicated in another scientific journal without permission by Editorial Board. If duplicate publications related to the papers of this journal are detected, the publication of the papers can be disapproved in the journal based on the decision of the Editorial Board. If the authors wish to obtain a duplicate or secondary publication for various other reasons, such as for readers of a different language, they should obtain approval from the editors-in-chief of both the first and second journal.
- 8. Obligation to register clinical trial
- Clinical trial defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” should be registered to the primary registry to be prior publication. Annals of Hepato-Biliary-Pancreatic Surgery accepts the registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (https://www.who.int/clinical-trials-registry-platform/) as well as https://www.anzctr.org.au,
http://www.clinicaltrials.gov/, http://www.isrctn.org/, https://www.umin.ac.jp/ctr/, and http://www.trialregister.nl/. The clinical trial registration number shall be published at the end of the abstract. Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement (http://www.consort-statement.org).
- 9. Data sharing statement to clinical trial
- Annals of Hepato-Biliary-Pancreatic Surgery accepts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines from 1 July 2018. Authors may refer to the editorial, “Data Sharing statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors,” in Journal of Korean Medical Science Vol. 32, No. 7:1051-1053
A preprint can be defined as a version of a scholarly paper that precedes formal peer review and publication in a peer-reviewed scholarly journal. AHBPS allows authors to submit the preprint
to the journal. It is not treated as duplicate submission or duplicate publication. AHBPS recommend authors to disclose it with DOI
in the letter to the editor during the submission process. Otherwise, it may be screened from the plagiarism check program—Similarity Check. Preprint submission will be processed through the same peer-review process with a usual submission. If the preprint is accepted for publication, authors are recommended to update the info at the preprint with a link to the published article in AHBPS, including DOI at AHBPS. It is strongly recommended that authors cite the article in AHBPS instead of the preprint at their next submission to journals.
Manuscript may be sent either directly to the Editorial Office or submitted via online through the website (http://www.ahbps.org). Annals of Hepato-Biliary-Pancreatic Surgery uses an online submission and review system. Please register with our online submission system or contact the Editorial Office if you are unable to submit via online.
Peer Review and Acceptance
The journal utilizes anonymous peer-review in evaluating manuscripts for publication. Submitted papers will be reviewed by three referees (at least two), and decisions will be available within two months. With respect to the revision and resubmission of manuscripts, it is the journal's policy to allow a couple of resubmission only, which should be received within 20 days from the time of receipt of the initial review letter. In general, a manuscript requiring more than a couple of revision or returned beyond 3 months will be handled as a new submission.
Type of Manuscripts
Contributions may be submitted as original articles, How-I-Do-It technical reports, case reports, review articles and editorials. How-I-Do-It technical reports cover the surgical techniques of major concerns on hepatobiliary and pancreatic surgery. Review articles and editorials are invited by the editorial board. However, authors who are interested in contributing reviews are requested to first contact the Editor-in-Chief with an outline of the proposed article.
Cover letter should inform the editor that neither the submitted material nor portions have been published previously or are under consideration for publication elsewhere. When more than one related manuscript has been published or is under consideration for publication by this or other journals, authors are required to declare this in their letter and to enclose copies of those publications for an editorial perusal. Failure to do so may lead to automatic rejection of the submitted manuscript. The corresponding author should certify that all listed authors participated meaningfully in the study and that they have seen and approved the final manuscript. The cover letter must briefly explain each author’s individual contributions.
Preparation of Manuscript
The manuscript must be written with double-line spacing and 3 cm margins on A4 sized format. Number pages consecutively, beginning from the title page.
Original article must arranged as follows: (1) title page (2) abstract (250 words or less with a list of 5 or less key words), (3) introduction, (4) materials and methods (or patients and methods), (5) results, (6) discussion, (7) acknowledgements, (8) conflict of interest statement, (9) references, (10) tables, (11) figure legends, and (12) figures on separate pages.
How-I-Do-It technical reports consist of (1) title page, (2) abstract (250 words or less with a list of 5 or less key words), (3) introduction, (4) description of surgical techniques, (5) discussion, (6) references, (7) tables and figure legends and (8) figures on separate pages.
Case reports consist of (1) title page, (2) abstract (250 words or less with a list of 5 or less key words), (3) introduction, (4) cases, (5) discussion, (6) references (20 or less), (7) tables and figure legends and (8) figures on separate pages. The manuscript should be written in English.
- 1. Title page
- Provide a concise title. List the full names of all authors and their institutional affiliation. In a multi-authored work involving more than a single institution, indicate individual affiliation by means of superscript Arabic numbers. Indicate a change of address in a similar fashion. List the footnotes to the title page. Provide the contact information for the corresponding author (name, address, telephone number, fax number, and e-mail address), and running title. Information on the research funding sources should be provided. All abbreviations should be explained in this page (e.g. BDR, bile duct resection; ICG, indocyanine green).
- 2. Abstract
- Abstract of original articles must contain 250 words or less and must be organized as follows: Backgrounds/Aims, Methods, Results, and Conclusions. Five or less key words from MeSH terms
(http://www.nlm.nih.gov/mesh/meshhome.html) should be provided at the end of the abstract.
Abstracts of How-I-Do-It technical reports and case reports must contain 250 words or less in unstructured form. All abstracts should be written in English. Key words up to five words are provided according to the MeSH terminology (http://www.nlm.nih.gov/mesh/meshhome.html) at the bottom of abstract.
- 3. Introduction
- The rationale for the study should be summarized and pertinent background material outlined. The introduction should not contain either results or conclusions. Provide the minimum background information that will orient the general reader. Do not engage in a literature review.
- 4. Materials and Methods
- Methods should be described in sufficient detail so that another investigator could repeat the work. The location (manufacturer name, city, state, country) of a manufacturer listed in the text should be included. Statistical methods used should be outlined. Ethical guidelines for human or animal study should be described and approval of institutional human research review committee or animal welfare committee should be cited. Describe in detail hazardous procedures or chemicals involved, including precautions observed. Provide a level of detail such that another investigator could repeat the work. For methods that are used without significant modification, citation of the original work will suffice. Identify and provide references for all the statistical methods used.
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
- 5. Results
- Results should be presented in logical sequence in the text. Tables and illustrations and repetitive presentation of the same data in different forms should be avoided. The results should not include material appropriate to the discussion. Present the major findings of the study in graphical form if practicable. Do not illustrate minor details if their message is adequately conveyed by simple descriptive text. Mention all the tables and figures.
- 6. Discussion
- Discussion should explain results in relation to any hypotheses advanced in the introduction. This may include an evaluation of the methodology and of the relationship of new information to the existing corpus of knowledge in that field. Data given in the results section should not be reiterated here. Concisely present the implications of the new findings for the field as a whole, minimizing any reiteration of the results and avoid repetition of material in the introduction; keeping a close focus on the specific topic of the paper.
- 7. Acknowledgements
- A brief acknowledgement of persons who made a genuine contribution may be included. Authors are responsible for obtaining written permission to use any copyrighted text and/or illustration.
- 8. Author’s Contributions
- Authors must include a statement to specify the contributions of each co-author. The statement can be up to several sentences long, describing the specific contributions made by each author (list the authors’ initials, e.g., ABC). The name of each author must appear at least once in any of the following categories; conception and design of study, acquisition of data, analysis and/or interpretation of data, drafting the manuscript, revising the manuscript critically for important intellectual content.
- 9. References
- References should be numbered serially in the order of appearance in the text, with numbers in brackets [ ]. List all authors if the number of authors is less than 7. List first six authors followed by et al if the number of authors is 7 or more. Journal titles are abbreviated in accordance with the style of Index Medicus. For more on references, refer to the National Library of Medicine (NLM) Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine).
Articles in journals:
- - References to an article with 6 or fewer authors:
Kim IG, Xu W, Wang HJ, Park YK, Kim BW. Variation or newly identified glissonian pedicles between the lateral and medial sections of the liver, using cadaver dissection. J Korean Surg Soc 2013;85:261-268.
- - References to an article with more than 6 authors:
Seo SI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, et al. Comparison of survival outcomes following segmental bile duct resection versus pancreatoduodenectomy for mid bile duct cancer. Korean J Hepatobiliary Pancreat Surg 2011;15:42-49.
- Book chapters:
Bruix J, Branco FS, Ayuso C. Hepatocellular carcinoma. In: Schiff ER, Sorrell MF, Maddrey WC, ed. Schiff's diseases of the liver. Vol I. 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1253-1263.
World Health Organization (WHO). WHO statistical information system [Internet]. Geneva: WHO 2014 [cited 2014 Feb 1]. Available from: http://www.who.int/research/en/.
- 10. Tables
- Each table must be simple and typed on a separate page with its heading above it. Explanatory matter should be placed in footnotes below the tabular matter and should not be included in the heading.
All non-standard abbreviations should be explained in the footnotes.
Table footnotes should be indicated by superscript-lowercase alphabet.
Statistical measures such as SD or SEM should be identified. Vertical rules and horizontal rules between entries should be omitted. Each table should be referred in the text consecutively and numbered according in order of citation. Tables should also be typed double-spaced, including headings. Larger size sheets must not be utilized.
- 11. Figures legends
- Figure legends should be typed double-spaced on a separate sheet. Symbols, arrows, and letters should be used to indicate parts of illustrations. Each figure should be referred in the text consecutively and should be numbered according in order of citation.
- 12. Figures
- We encourage authors to use color figures when they will enhance the presentation of the data. Illustrations should be sharp and presented in the TIF, BMP or PPT format at the time of submission. Figures should be supplied in the TIF or BMP format at a final resolution of not less than 300 dpi. Do not use JPG format for clear printing, except for very large-sized images. Each figure should be less than 10 MB in size for electronic upload. Please contact to the Editorial Office when very large files are submitted. Microscopic pictures should be explained according to the staining method and scaled by the power of magnification (e.g., H&E stain, x 400). Authors are charged only for color figures of the offprint. Color figures of electronic publication (PDF file) are free of charge, thus we suggest submitting color figures.
- 13. Terminology
- Medical terminology should be followed by the recent terminology book published by the Korean Medical Association (http://term.kma.org/).
- 14. Abbreviations
- Abbreviations should be used in case that they appear in the text at least 3 times and should be explained in parentheses in its first use in the text. Do not use abbreviation in the title.
- 15. Units of measurement
- Laboratory measurements should be used in SI units (International System of Units). The metric system is preferred for the expression of length, area, mass, and volume.
- 16. Permissions
- Direct quotations, tables or illustrations taken from copy-righted material must be accompanied by written permission for their use fro the publisher. The permission is presented as a footnote or addition to the legend and it must provide complete information as to the source. Photographs of identifiable persons must be accompanied by a signed release that indicates their informed consent.
- 17. Author’s manuscript checklist
- The manuscript is not concurrently submitted to other journals.
- The manuscript is arranged in following order: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgement, Reference, Legends.
- Font of the main text is 11-point size.
- Pages are numbered consecutively from abstract to legends on the last page.
- Corresponding author name, address, telephone number, fax number, and ORCID (Open Researcher and Contributor ID) in Title page.
- Information on the name(s) and affiliation(s) of the author(s) is not disclosed in the manuscript except the Title page.
- The abstract should not exceed 250 words for English abstract, respectively. The abstracts should contain the same contents.
- Key words (less than 5) are provided (should be inserted in the submission step).
- Tables, graphs, and drawings are brief and self-explanatory.
- Each title of the tables, graphs, and drawings is also selfexplanatory.
- All tables and figures are uploaded in a separated file.
- Figures are separated from figure legends.
- Figure resolutions are higher than 600 dpi. And figures are at their actual (print) size.
- References are in the correct style.
Article Processing Charges
The article processing charges, or APC is currently waived since May 2022, and all authors are welcome to submit and publish their works free of charge.
Copyrights of all published materials are owned by AHBPS. All authors must sign the Transfer of Copyright Agreement when they submit their manuscript. Materials appearing in the journal are covered by copyright. The authors are responsible for obtaining permission from the copyright holder to reprint in AHBPS any previously published material. AHBPS is an open access journal under the terms of the Creative Commons Attribution on-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/). Please see our Open Access Policy.